A 65-year-old woman with dilated cardiomyopathy (ejection fraction 25%) presents with recurrent episodes of polymorphic ventricular tachycardia. She is intolerant to beta-blockers (severe hypotension). Which drug is the preferred first-line choice for long-term suppression of polymorphic VT in this setting?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.